Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells - PubMed (original) (raw)

. 1995 Apr 15;55(8):1639-42.

Affiliations

PMID: 7712467

Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells

K J Russell et al. Cancer Res. 1995.

Abstract

We have examined the effect of abrogation of the G2 checkpoint on the radiosensitivity of G1 checkpoint-proficient and G1 checkpoint-deficient cells. A549 human lung adenocarcinoma cells were transduced with the E6 oncogene of the human papillomavirus type 16 to eliminate their radiation-induced G1 arrest. These E6+ cells exhibited a dose-dependent increase in radiation resistance compared to control A549 cells transduced with the vector alone. Treatment (96 h) with 2 mM caffeine resulted in an abrogation of the cellular G2 checkpoint in both E6+ and control cells and a differential radiosensitizing effect on the two cell lines such that the E6+ clones and the vector controls became equally radiosensitive. These data show that human tumors which are radioresistant due to the loss of the p53-mediated G1 checkpoint can be made radiosensitive by abrogation of the G2 checkpoint. The implications of these results for cancer therapy are discussed.

PubMed Disclaimer

Cited by

p53-dependent G(1) arrest in 1st or 2nd cell cycle may protect human cancer cells from cell death after treatment with ionizing radiation and Chk1 inhibitors.
Petersen L, Hasvold G, Lukas J, Bartek J, Syljuåsen RG. Petersen L, et al. Cell Prolif. 2010 Aug;43(4):365-71. doi: 10.1111/j.1365-2184.2010.00685.x. Cell Prolif. 2010. PMID: 20590661 Free PMC article.
90-kDa heat shock protein inhibition abrogates the topoisomerase I poison-induced G2/M checkpoint in p53-null tumor cells by depleting Chk1 and Wee1.
Tse AN, Sheikh TN, Alan H, Chou TC, Schwartz GK. Tse AN, et al. Mol Pharmacol. 2009 Jan;75(1):124-33. doi: 10.1124/mol.108.050807. Epub 2008 Sep 26. Mol Pharmacol. 2009. PMID: 18820127 Free PMC article.
HRAD1 and MRAD1 encode mammalian homologues of the fission yeast rad1(+) cell cycle checkpoint control gene.
Udell CM, Lee SK, Davey S. Udell CM, et al. Nucleic Acids Res. 1998 Sep 1;26(17):3971-6. doi: 10.1093/nar/26.17.3971. Nucleic Acids Res. 1998. PMID: 9705507 Free PMC article.
Immunogenic cell death after combined treatment with radiation and ATR inhibitors is dually regulated by apoptotic caspases.
Eek Mariampillai A, Hauge S, Kongsrud K, Syljuåsen RG. Eek Mariampillai A, et al. Front Immunol. 2023 Jun 6;14:1138920. doi: 10.3389/fimmu.2023.1138920. eCollection 2023. Front Immunol. 2023. PMID: 37346039 Free PMC article.
Exploiting the p53 Pathway for Therapy.
Cheok CF, Lane DP. Cheok CF, et al. Cold Spring Harb Perspect Med. 2017 Mar 1;7(3):a026310. doi: 10.1101/cshperspect.a026310. Cold Spring Harb Perspect Med. 2017. PMID: 28193768 Free PMC article. Review.

Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells - PubMed (original) (raw)